Trial intelligence / Profile preview

Bioequivalence study of Etoricoxib 120 mg tablets versus Arcoxia 120 mg tablets in healthy Thai volunteers under fasting conditions

TCTR20190316004Phase 1Not yet recruiting

Sponsor
Bio-innova
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of etoricoxib (2 arms), sponsored by Bio-innova. Planned start Jul 2019; status: not yet recruiting.

02

Drugs

etoricoxib

Beyond the preview

Go deeper on TCTR20190316004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190316004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call